These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19432837)

  • 1. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.
    Ramakrishnan S; Heung YM; Round J; Morris TP; Collinson P; Williams AF
    Acta Paediatr; 2009 Aug; 98(8):1254-9. PubMed ID: 19432837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
    König K; Guy KJ; Drew SM; Barfield CP
    Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes of brain-type natriuretic peptide in preterm neonates.
    da Graca RL; Hassinger DC; Flynn PA; Sison CP; Nesin M; Auld PA
    Pediatrics; 2006 Jun; 117(6):2183-9. PubMed ID: 16740863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates.
    Flynn PA; da Graca RL; Auld PA; Nesin M; Kleinman CS
    J Pediatr; 2005 Jul; 147(1):38-42. PubMed ID: 16027692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.
    Sanjeev S; Pettersen M; Lua J; Thomas R; Shankaran S; L'Ecuyer T
    J Perinatol; 2005 Nov; 25(11):709-13. PubMed ID: 16222347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: How and when?
    Liu Y; Huang ZL; Gong L; Zhang Z; Zhang SC; Zhou YX
    Clin Hemorheol Microcirc; 2020; 75(3):335-347. PubMed ID: 32280084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
    Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
    Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.
    Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW
    Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
    Hariu CD; Saunders AB; Gordon SG; Norby B; Miller MW
    J Vet Cardiol; 2013 Sep; 15(3):197-204. PubMed ID: 23933478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction.
    Khan SQ; Quinn P; Davies JE; Ng LL
    Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].
    Lu KS; Guo XL; Lv JF; Huang SL; Yang CH; Zou ZH; Chen ZJ; Lai CH; Yang BY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P; Chongkongkiat P; Khositseth A
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants.
    El-Khuffash AF; Slevin M; McNamara PJ; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F133-7. PubMed ID: 21071684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage.
    El-Khuffash A; Barry D; Walsh K; Davis PG; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.
    Attridge JT; Kaufman DA; Lim DS
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F178-82. PubMed ID: 18981033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin reflectance changes in preterm infants with patent ductus arteriosus.
    De Felice C; Mazzieri S; Pellegrino M; Del Pasqua A; Toti P; Bagnoli F; Rosati E; Latini G
    Early Hum Dev; 2004 Jun; 78(1):45-51. PubMed ID: 15177671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants.
    Puddy VF; Amirmansour C; Williams AF; Singer DR
    Clin Sci (Lond); 2002 Jul; 103(1):75-7. PubMed ID: 12095406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
    Letshwiti JB; Sirc J; O'Kelly R; Miletin J
    Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.